{"disease":{"id":"lesion-femoral","name":"lesion femoral"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05216731","title":"Bypass Versus Endovascular Procedure in Long Lesions of the Superficial Femoral Artery in the Claudicant","phase":"NA","overall_status":"RECRUITING","enrollment_count":290,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT05445258","title":"Safety and Tolerance of the Use of InnoCath AB® Hyper-compliant Balloon","phase":"NA","overall_status":"TERMINATED","enrollment_count":3,"lead_sponsor_name":"InnoRa GmbH","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}